[ad_1] Q3 2025 Revenue of $1.7 Million Revenue driven by 96% year-over-year growth in the Population Health segment Gross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024 Net […]

[ad_1] Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the […]

[ad_1] CARMEL, Ind., Sept. 11, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA), (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, today announced the pricing of a public […]